Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Fasting, calculated mean LDL-C ≥130 mg/dL and ≤220 mg/dL~* Fasting mean TG level ≤400 mg/dL~* Stable statin therapy for at least 3 months prior to screening: atorvastatin (10 or 20 mg daily), simvastatin (5, 10 or 20 mg daily), rosuvastatin (5 or 10 mg daily), or pravastatin (10, 20 or 40 mg daily)~Exclusion Criteria:~* Clinically significant cardiovascular disease within 12 months of screening~* Current muscle-related symptoms that may be due to ongoing statin therapy or a history of certain lab abnormalities that occurred during statin therapy and resolved when statin therapy was discontinued~* Type 1 diabetes or uncontrolled type 2 diabetes~* Use of metformin or thiazolidinediones (TZD) within 4 weeks of screening~* History of chronic musculoskeletal symptoms such as fibromyalgia~* Uncontrolled hypothyroidism~* Liver disease or dysfunction~* Renal dysfunction or nephritic syndrome~* Gastrointestinal conditions or procedures or surgeries~* Hematologic or coagulation disorders or low hemoglobin levels~* HIV or AIDS~* History of malignancy~* History of drug or alcohol abuse within 2 years~* Use of experimental or investigational drugs within 30 days of screening~* Use of ETC-1002 in a previous clinical study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- ETC-1002 120 mg/day (Type: EXPERIMENTAL): Orally, once daily in morning as capsules
- ETC-1002 180 mg/day (Type: EXPERIMENTAL): Orally, once daily in morning as capsules
- Placebo (Type: PLACEBO_COMPARATOR): Orally, once daily in morning

Based on this trial design, predict the completion outcome and termination type (if applicable).